1. Using beta 2-stimulants in asthma. Drug Ther Bull 1997; 35 (1): 1–4.
2. Godfrey S, Bar-Yishay E. Exercised-induced asthma revisited. Respir Med 1993; 87 (5): 331–44.
3. Vathenen AS, Britton JR, Ebden P et al. High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis 1988; 138 (4): 850–5.
4. Gross NJ, Petty TL, Friedman M et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis 1989; 139 (5): 1188–91.
5. Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ 1988; 297 (6662): 1506–10.
6. Higgins BG, Powell RM, Cooper S, Tattersfield AE. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J 1991; 4 (4): 415–20.
7. Dolovich MB, Ahrens RC, Hess DR et al. Device selection and outcomes of aerosol therapy: Evidence_based guidelines:American College of Chest Physicians/American Collegeof Asthma, Allergy, and Immunology. Chest 2005; 127: 335–71.
8. Langley PC. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers. Clin Ther 1999; 21 (1): 236–53.
9. Newman SP. A comparison of lung deposition patterns between different asthma inhalers. J Aerosol Med 1995; 8 (Suppl. 3): 21–6S.
10. Newman SP. Inhaler treatment options in COPD. Eur Respir Rev 2005; 14 (96): 102–8.
11. Kim CS, Kang TC. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. Am J Respir Crit Care Med 1997; 155 (3): 899–905.
12. Авдеев С.Н. Устройства доставки ингаляционных препаратов, используемые при терапии заболеваний дыхательных путей. РМЖ. 2002; 10 (5): 255.
13. Бронхиальная астма. Глобальная стратегия: совместный доклад Национального института сердце, легкие, кровь и Всемирной организации здравоохранения. Атмосфера, 2002.
14. Цой А.Н., Архипов В.В. Вопросы клинической фармакологии β2-адреностимуляторов. Рус. мед. журн. 2001; 9 (21): 930–3.
15. Шмелев Е.И. Амбулаторное лечение больных бронхиальной астмой и хронической обструктивной болезнью легких: результаты Всероссийской программы СВОБОДА. Справ. поликлинич. врача. 2007; 11: 57–62.
16. Черняк А.В. Бронходилатационная проба. Справ. поликлинич. врача. 2008; 10: 42–44.